Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family

被引:304
作者
Bour-Jordan, Helene [1 ]
Esensten, Jonathan H. [1 ]
Martinez-Llordella, Marc [1 ]
Penaranda, Cristina [1 ]
Stumpf, Melanie [1 ]
Bluestone, Jeffrey A. [1 ]
机构
[1] Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA
关键词
costimulation; tolerance; CD28; CTLA-4; PD-1; Tregs; LYMPHOCYTE-ASSOCIATED ANTIGEN-4; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NONOBESE DIABETIC MICE; FUNCTION IN-VIVO; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIORGAN TISSUE DESTRUCTION; KAPPA-B ACTIVATION; PROTEIN-KINASE-C; CUTTING EDGE; DENDRITIC CELLS;
D O I
10.1111/j.1600-065X.2011.01011.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Positive and negative costimulation by members of the CD28 family is critical for the development of productive immune responses against foreign pathogens and their proper termination to prevent inflammation-induced tissue damage. In addition, costimulatory signals are critical for the establishment and maintenance of peripheral tolerance. This paradigm has been established in many animal models and has led to the development of immunotherapies targeting costimulation pathways for the treatment of cancer, autoimmune disease, and allograft rejection. During the last decade, the complexity of the biology of costimulatory pathways has greatly increased due to the realization that costimulation does not affect only effector T cells but also influences regulatory T cells and antigen-presenting cells. Thus, costimulation controls T-cell tolerance through both intrinsic and extrinsic pathways. In this review, we discuss the influence of costimulation on intrinsic and extrinsic pathways of peripheral tolerance, with emphasis on members of the CD28 family, CD28, cytotoxic T-lymphocyte antigen-4 (CTLA-4), and programmed death-1 (PD-1), as well as the downstream cytokine interleukin-1 (IL-2).
引用
收藏
页码:180 / 205
页数:26
相关论文
共 277 条
[1]  
Aaltonen J, 1999, ANN MED, V31, P111, DOI 10.3109/07853899708998786
[2]   CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris [J].
Abrams, JR ;
Lebwohl, MG ;
Guzzo, CA ;
Jegasothy, BV ;
Goldfarb, MT ;
Goffe, BS ;
Menter, A ;
Lowe, NJ ;
Krueger, G ;
Brown, MJ ;
Weiner, RS ;
Birkhofer, MJ ;
Warner, GL ;
Berry, KK ;
Linsley, PS ;
Krueger, JG ;
Ochs, HD ;
Kelley, SL ;
Kang, SW .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1243-1252
[3]   The role of positive costimulatory molecules in transplantation and tolerance [J].
Agarwal, Avinash ;
Newell, Kenneth A. .
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2008, 13 (04) :366-372
[4]   The NOD mouse: A model of immune dysregulation [J].
Anderson, MS ;
Bluestone, JA .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :447-485
[5]   Projection of an immunological self shadow within the thymus by the aire protein [J].
Anderson, MS ;
Venanzi, ES ;
Klein, L ;
Chen, ZB ;
Berzins, SP ;
Turley, SJ ;
von Boehmer, H ;
Bronson, R ;
Dierich, A ;
Benoist, C ;
Mathis, D .
SCIENCE, 2002, 298 (5597) :1395-1401
[6]   CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression [J].
Appleman, LJ ;
Berezovskaya, A ;
Grass, I ;
Boussiotis, VA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :144-151
[7]   Genetic Evidence That the Differential Expression of the Ligand-Independent Isoform of CTLA-4 Is the Molecular Basis of the Idd5.1 Type 1 Diabetes Region in Nonobese Diabetic Mice [J].
Araki, Manabu ;
Chung, Denise ;
Liu, Sue ;
Rainbow, Daniel B. ;
Chamberlain, Giselle ;
Garner, Valerie ;
Hunter, Kara M. D. ;
Vijayakrishnan, Lalitha ;
Peterson, Laurence B. ;
Oukka, Mohamed ;
Sharpe, Arlene H. ;
Sobel, Raymond ;
Kuchroo, Vijay K. ;
Wicker, Linda S. .
JOURNAL OF IMMUNOLOGY, 2009, 183 (08) :5146-5157
[8]   Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism [J].
Arreaza, GA ;
Cameron, MJ ;
Jaramillo, A ;
Gill, BM ;
Hardy, D ;
Laupland, KB ;
Rapoport, MJ ;
Zucker, P ;
Chakrabarti, S ;
Chensue, SW ;
Qin, HY ;
Singh, B ;
Delovitch, TL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2243-2253
[9]  
Bachmann MF, 1999, J IMMUNOL, V163, P1128
[10]  
BALZANO C, 1992, INT J CANCER, P28